Terminal · Institutions

Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.

Empery Asset Management, LP 13F Holdings -- Portfolio & Top Positions (2026-03-31)

Empery Asset Management, LP (CIK 1469336) reported $83.0M across 29 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: XFOR ($36.9M, 44.50%), EMPD ($12.4M, 14.93%), DTIL ($10.8M, 13.04%), IMPP ($3.8M, 4.52%), VENU ($3.3M, 4.02%). Source: SEC Form 13F.

RankTickerCompanyValue% PortfolioSharesAction
1XFORX4 PHARMACEUTICALS INC$36.9M44.50%8.9MTrimmed
2EMPDEMPERY DIGITAL INC$12.4M14.93%2.9MHold
3DTILPRECISION BIOSCIENCES INC$10.8M13.04%2.0MTrimmed
4IMPPIMPERIAL PETE INC$3.8M4.52%877,645Trimmed
5VENUVENU HLDG CORP$3.3M4.02%1.0MNew
6TNYATENAYA THERAPEUTICS INC$3.0M3.58%4.3MTrimmed
7SCYXSCYNEXIS INC$1.7M2.04%1.8MNew
8USEGU S ENERGY CORP DEL$1.7M2.04%1.9MNew
9CYNCYNGN INC$1.6M1.92%957,784New
10JAGUAR URANIUM CORP$1.3M1.61%487,500New
11MSCLFSATELLOS BIOSCIENCE INC$1.3M1.56%230,100New
12CRMLCRITICAL METALS CORP$1.0M1.26%132,039Trimmed
13URGUR-ENERGY INC$924,0031.11%620,136New
14PMNPROMIS NEUROSCIENCES INC$766,4830.92%60,353New
15SLGGSUPER LEAGUE ENTERPRISE INC$491,7930.59%132,917New
16ACRXTALPHERA INC$441,0300.53%590,481Trimmed
17BNTCBENITEC BIOPHARMA INC$324,1860.39%30,440Trimmed
18BCTXZBRIACELL THERAPEUTICS CORP$309,0300.37%300,000New
19ABTSABITS GROUP INC$266,0520.32%172,761New
20PRZOPARAZERO TECHNOLOGIES LTD$217,5750.26%282,199New
21NASUS PHARMA LTD$101,6830.12%45,803New
22BCTXZBRIACELL THERAPEUTICS CORP$93,3240.11%666,600Hold
23MTEKWMARIS TECH LTD$44,9380.05%297,600Hold
24NTRBWNUTRIBAND INC$45,0440.05%40,218Hold
25RTACWRENATUS TACTICAL ACQUIS$23,0050.03%50,000Hold

Source: SEC Form 13F filings · as of 2026-03-31